Systems Analysis and Improvement Approach to Prevent TB
SAIA-TB
SAIA-TB: Using the Systems Analysis and Improvement Approach (SAIA) to Prevent TB in Rural South Africa
2 other identifiers
interventional
19,560
1 country
16
Brief Summary
This randomized trial uses the evidence-based Systems Analysis and Improvement Approach (SAIA) adapted for tuberculosis (SAIA-TB) to assess the comprehensive tuberculosis (TB) care cascade across 16 clinics in rural Eastern Cape, South Africa to improve patient outcomes. The aims of this study are to:
- Evaluate the effectiveness of SAIA-TB use in clinics on TB cascade outcomes for TB patients and with high-risk contacts
- Determine the drivers of SAIA-TB implementation success or failure across clinics The investigators hypothesize that SAIA-TB implementation will lead to a 20% increase in each of: TB screening, TB preventive treatment initiation, and TB disease treatment initiation during the 18-month intervention period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2025
Longer than P75 for not_applicable
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2024
CompletedFirst Posted
Study publicly available on registry
March 18, 2024
CompletedStudy Start
First participant enrolled
February 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 28, 2029
May 6, 2025
May 1, 2025
3.1 years
March 11, 2024
May 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
TB Screening
The proportion of individuals screened with WHO TB symptom screen in the target population
18 months
Linkage to care for TB disease treatment
The proportion of individuals initiating TB disease treatment among those with a positive diagnostic evaluation
18 months
Linkage to care for TB preventive treatment
The proportion of individuals initiating TB preventive treatment among those with a negative diagnostic evaluation and eligible for TPT
18 months
Secondary Outcomes (4)
Successful TB Prevention Treatment (TPT) Outcome
18 months
Successful TB Outcome
18 months
TB Evaluation
18 months
TB Diagnosis
18 months
Study Arms (2)
Exposed
OTHERClinics are considered exposed after intensive SAIA-TB intervention, implementation phase, and maintenance phase.
Unexposed
NO INTERVENTIONClinics are considered unexposed prior to the initiation of SAIA-TB in their clinic
Interventions
The Systems Analysis and Improvement Approach for TB (SAIA-TB) is a five-step systems analysis and iterative improvement cycle intervention which will be implemented by clinic staff with support from study personnel in intervention clinics. Components of the intervention include TB cascade analysis, patient flow mapping and continuous quality improvement, aimed to incrementally optimize TB screening, evaluation, diagnosis, TB preventive therapy and TB disease treatment initiation, successful treatment, and TB-free survival among the population at the intervention clinics.
Eligibility Criteria
You may qualify if:
- Location in the municipalities of Dr. Beyers Naude, Blue Crane Route, Makana, Ndlambe, Sundays River Valley, Kou-Kamma, or Kouga within the Sarah Baartman district, Eastern Cape, South Africa
- Within 2 hours' drive to Gqeberha, where the study office is located
- Only one clinic per town/area/location to ensure a mix of rural, semi-rural, semi urban
- Clinic capacity/Patient volume \> 700 total outpatient attendees per month (8,400 patients per year)
- Staff size of at least 5 employees with a mixture of at least 2 professional nurses, 1 or 2 pharmacist/pharmacy technicians, at least 1 data capturer, a social worker, and multiple community health workers who are clinic-based or part of ward-based outreach teams.
- Must have an acting Clinic Manager
You may not qualify if:
- Clinic managers and/or staff are unwilling to participate
- Aim 2:
- years and older
- Frontline clinical and/or managerial staff, district-level TB management
- Ability to provide informed consent
- Under age 18
- Unwilling to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Boston Collegelead
- National Institutes of Health (NIH)collaborator
- Boston Universitycollaborator
- University of Washingtoncollaborator
- Medical Research Council, South Africacollaborator
- National Institute of Nursing Research (NINR)collaborator
Study Sites (16)
Addo Clinic
Addo, South Africa
Lukhanyiso Clinic
Addo, South Africa
Kwa-Nonqubela Clinic
Alexandria, South Africa
Marselle Clinic
Boesmansriviermond, South Africa
Masakhane Clinic
Hankey, South Africa
Humansdorp Clinic
Humansdorp, South Africa
Pellsrus Clinic
Jeffrey's Bay, South Africa
Joubertina CHC
Joubertina, South Africa
Louterwater Clinic
Joubertina, South Africa
Twee Riviere Clinic
Joubertina, South Africa
Kareedouw Clinic
Kareedouw, South Africa
Kenton On Sea Clinic
Kenton on Sea, South Africa
Kirkwood Clinic
Kirkwood, South Africa
Moses Mabida Clinic
Kirkwood, South Africa
Imizamo Yetho Clinic
Patensie, South Africa
Nkwenkwezi Clinic
Port Alfred, South Africa
Related Publications (1)
van de Water BJ, Brooks MB, Matji R, Ncanywa B, Dikgale F, Abuelezam NN, Mzileni B, Nokwe M, Moko S, Mvusi L, Loveday M, Gimbel S. Systems analysis and improvement approach to optimize tuberculosis (SAIA-TB) screening, treatment, and prevention in South Africa: a stepped-wedge cluster randomized trial. Implement Sci Commun. 2024 Apr 16;5(1):40. doi: 10.1186/s43058-024-00582-z.
PMID: 38627799DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brittney J van de Water, PhD
Boston College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2024
First Posted
March 18, 2024
Study Start
February 6, 2025
Primary Completion (Estimated)
February 29, 2028
Study Completion (Estimated)
February 28, 2029
Last Updated
May 6, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share